Clinical Trial

Iron Status of Non-anemic Pregnant Women in First Trimester

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This cross-sectional study aims to establish reference intervals for iron biomarkers-including serum iron, ferritin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT)-in healthy pregnant women during the first trimester. Additionally, the study will investigate the current prevalence of non-anemic iron deficiency (NAID) in this population. By applying strict inclusion and exclusion criteria to eliminate potential confounding factors, the study seeks to provide a reliable baseline for evaluating iron status and early detection of iron deficiency without anemia among pregnant women.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-18.
Trial Details
NCT Number NCT06990373
Lead Sponsor Hung Vuong Hospital
Conditions Iron Deficiency (Without Anemia), Reference Values, Iron Deficiency Without Anemia
Enrollment 600 participants
Start Date 2025-03-12
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-30